Researchers produced chitosan-coated alginate nanoparticles containing insulin using an emulsification method. They characterized the nanoparticles in terms of size, surface charge, polymer interactions, and insulin encapsulation efficiency. Chitosan coating increased nanoparticle size from 1.58 to 18.11 micrometers and changed surface charge from negative to positive. Fourier transform infrared spectroscopy and differential scanning calorimetry showed electrostatic interactions between alginate and chitosan formed a polyelectrolyte complex coating. Both coated and uncoated nanoparticles achieved around 70% encapsulation efficiency of insulin. The study demonstrated chitosan-reinforced alginate nanoparticles have potential for oral delivery of insulin.
Researchers produced chitosan-coated alginate nanoparticles containing insulin using an emulsification method. They characterized the nanoparticles in terms of size, surface charge, polymer interactions, and insulin encapsulation efficiency. Chitosan coating increased nanoparticle size from 1.58 to 18.11 micrometers and changed surface charge from negative to positive. Fourier transform infrared spectroscopy and differential scanning calorimetry showed electrostatic interactions between alginate and chitosan formed a polyelectrolyte complex coating. Both coated and uncoated nanoparticles achieved around 70% encapsulation efficiency of insulin. The study demonstrated chitosan-reinforced alginate nanoparticles have potential for oral delivery of insulin.
Researchers produced chitosan-coated alginate nanoparticles containing insulin using an emulsification method. They characterized the nanoparticles in terms of size, surface charge, polymer interactions, and insulin encapsulation efficiency. Chitosan coating increased nanoparticle size from 1.58 to 18.11 micrometers and changed surface charge from negative to positive. Fourier transform infrared spectroscopy and differential scanning calorimetry showed electrostatic interactions between alginate and chitosan formed a polyelectrolyte complex coating. Both coated and uncoated nanoparticles achieved around 70% encapsulation efficiency of insulin. The study demonstrated chitosan-reinforced alginate nanoparticles have potential for oral delivery of insulin.
Upcoming challenge for oral insulin: formulation and characterization of chitosan- reinforced
insulin alginate nanoparticles
C. Reis1, A. Ribeiro2, S. Vilela1, F. Veiga1 1 Pharmaceutics, Faculty of Pharmacy of Coimbra, Portugal, 2Pharmaceutics, ISCSN - Porto, Portugal Purpose. To produce chitosan-coated alginate nanoparticles by emulsification/internal gelation, using insulin as a model protein, and to characterize them on the following parameters: size distribution, interactions between alginate and chitosan, zeta potential and encapsulation efficiency of insulin. Methods. Alginate nanoparticles were prepared by an emulsification-based method using an internal calcium source. The resultant nanoparticles were recovered using organic solvents and ultracentrifugation. Chitosan-coating was applied by a two-stage method. Size distribution analysis of hydrated uncoated and coated nanoparticles was performed by laser diffraction spectroscopy (LDS). The interactions between the two polymers were assessed by differential scanning calorimetry (DSC) and Fourier-transform infrared spectrometry (FT-IR). The presence of chitosan on surface of alginate nanoparticles was assessed by zeta potential. At last, insulin encapsulation efficiency of coated and uncoated alginate nanoparticles was evaluated direct (by insulin release from precise amount of nanoparticles) and indirectly (by insulin losses during the process) using Bradford method. Results. Chitosan-coating led to an increase on mean diameter of alginate nanoparticles from 1.58 to 18.11 µm. The inclusion of chitosan led to significant change on surface charge of alginate nanoparticles (-16.3 mV to +14.55 mV). FT-IR as well DSC data suggested the formation of polyelectrolyte complex due to electrostatic interactions between carboxylate groups of alginate and ammonium groups of chitosan. Finally, coated nanoparticles provided similar encapsulation efficiency compared to uncoated nanoparticles with values around 70%. Conclusion. Chitosan-reinforced insulin alginate nanoparticles were successfully prepared by creating the appropriate conditions. These nanoparticles produced by emulsification/internal gelation have potential as carriers for oral delivery of insulin.